Terms: = Lung cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
6143 results:
1. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
2. Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract] [Full Text] [Related]
3. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract] [Full Text] [Related]
4. Tumour-derived exosome SNHG17 induced by oestrogen contributes to ovarian cancer progression via the CCL13-CCR2-M2 macrophage axis.
Liang H; Geng S; Wang Y; Fang Q; Xin Y; Li Y
J Cell Mol Med; 2024 May; 28(9):e18315. PubMed ID: 38680032
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell lung cancer.
Peng S; Huang H; Chen J; Ding X; Zhu X; Liu Y; Chen L; Lu Z
Technol Cancer Res Treat; 2024; 23():15330338241248573. PubMed ID: 38656242
[No Abstract] [Full Text] [Related]
6. Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression.
Zhuang W; Liu C; Hong Y; Zheng Y; Huang M; Tang H; Zhao L; Huang Z; Tu M; Yu L; Chen J; Zhang Y; Chen X; Lin F; Gao Q; Yu C; Huang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):123. PubMed ID: 38654325
[TBL] [Abstract] [Full Text] [Related]
7. Targeted inhibition of the PI3K/akt/mTOR pathway by (+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and autophagy in non-small cell lung cancer.
Li XQ; Cheng XJ; Wu J; Wu KF; Liu T
Cell Mol Biol Lett; 2024 Apr; 29(1):58. PubMed ID: 38649803
[TBL] [Abstract] [Full Text] [Related]
8. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.
Wu J; Wen T; Marzio A; Song D; Chen S; Yang C; Zhao F; Zhang B; Zhao G; Ferri A; Cheng H; Ma J; Ren H; Chen QY; Yang Y; Qin S
Cell Death Dis; 2024 Apr; 15(4):282. PubMed ID: 38643215
[TBL] [Abstract] [Full Text] [Related]
9. racGAP1 promotes lung cancer cell proliferation through the PI3K/akt signaling pathway.
Xu Z; Wu S; Tu J; Wang M; Liang W; Cheng J; Guan J; Xu J
Sci Rep; 2024 Apr; 14(1):8694. PubMed ID: 38622149
[TBL] [Abstract] [Full Text] [Related]
10. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract] [Full Text] [Related]
11. Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights.
M Ezzat S; M Merghany R; M Abdel Baki P; Ali Abdelrahim N; M Osman S; A Salem M; Peña-Corona SI; Cortés H; Kiyekbayeva L; Leyva-Gómez G; Sharifi-Rad J; Calina D
Mol Nutr Food Res; 2024 Apr; 68(8):e2400063. PubMed ID: 38600885
[TBL] [Abstract] [Full Text] [Related]
12. Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2.
Sun H; Zhu R; Guo X; Zhao P; Zhang R; Zhao Z; Zhou H
Pathol Res Pract; 2024 Apr; 256():155271. PubMed ID: 38574630
[TBL] [Abstract] [Full Text] [Related]
13. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract] [Full Text] [Related]
14. Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.
Mahmood N; Arakelian A; Szyf M; Rabbani SA
Exp Mol Med; 2024 Apr; 56(4):959-974. PubMed ID: 38556549
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment.
Huang X; Wu S; Chen S; Qiu M; Zhao Y; Wei J; He J; Zhao W; Tan L; Su C; Zhou S
Int Immunopharmacol; 2024 May; 132():111901. PubMed ID: 38554448
[TBL] [Abstract] [Full Text] [Related]
16. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients.
Wang N; Tan X; Cao S; Liu M
Pathol Res Pract; 2024 Apr; 256():155270. PubMed ID: 38552564
[TBL] [Abstract] [Full Text] [Related]
17. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-akt-mTOR signalling cascade.
Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
[TBL] [Abstract] [Full Text] [Related]
18. Recent advances in the therapeutic potential of nobiletin against respiratory diseases.
Qin Y; Yang J; Li H; Li J
Phytomedicine; 2024 Jun; 128():155506. PubMed ID: 38522319
[TBL] [Abstract] [Full Text] [Related]
19. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
[TBL] [Abstract] [Full Text] [Related]
20. L-Methionine accentuates anti-tumor action of Gefitinib in Gefitinib-resistant lung adenocarcinoma: Role of EGFR/ERK/akt signaling and histone H3K36me2 alteration.
Pal S; Kabeer SW; Tikoo K
Toxicol Appl Pharmacol; 2024 Apr; 485():116907. PubMed ID: 38521369
[TBL] [Abstract] [Full Text] [Related]
[Next]
